EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Kiora Pharmaceuticals's enterprise value is $-14.94 Mil.
Kiora Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was $0.00 Mil. Therefore, Kiora Pharmaceuticals's EV-to-Revenue for today is .
The historical rank and industry rank for Kiora Pharmaceuticals's EV-to-Revenue or its related term are showing as below:
KPRX'
s EV-to-Revenue Range Over the Past 10 Years
Min: -893.03 Med: 3.43 Max: 2733.68
Current: -0.93
During the past 13 years, the highest EV-to-Revenue of Kiora Pharmaceuticals was 2733.68. The lowest was -893.03. And the median was 3.43.
KPRX's EV-to-Revenue is ranked better than 93.38% of 997
companies
in the Biotechnology industry
Industry Median: 7.47
vs KPRX: -0.93
Kiora Pharmaceuticals EV-to-Revenue Historical Data
The historical data trend for Kiora Pharmaceuticals's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Kiora Pharmaceuticals's EV-to-Revenue
For the Biotechnology subindustry, Kiora Pharmaceuticals's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kiora Pharmaceuticals's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Kiora Pharmaceuticals's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Kiora Pharmaceuticals's EV-to-Revenue falls into.
Kiora Pharmaceuticals's current Enterprise Value is $-14.94 Mil.
Kiora Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kiora Pharmaceuticals's share price for today is $3.00.
Kiora Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kiora Pharmaceuticals EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Kiora Pharmaceuticals's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
KPRX has been successfully added to your 